SIBN News and Press, SI-BONE Inc. From 05/01/23

2023-05-01 16:17:56 ET SI-BONE press release ( NASDAQ: SIBN ): Q1 GAAP EPS of -$0.32 beats by $0.10 . Revenue of $32.71M (+45.8% Y/Y) beats by $3.55M . Record U.S. revenue of $30.5 million for the first quarter 2023, representing approximately 50% inc...

SANTA CLARA, Calif., May 01, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended March 31, 2023. Recent Highlights Record wo...

SANTA CLARA, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2023 Bank of America Merrill Lynch ...

SANTA CLARA, Calif., April 10, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the first quarter of 2023 after market close on Monday, Ma...

Gainers: Cardio Diagnostics ( CDIO ) +159% . Bioventus ( BVS ) +68% . CNS Pharmaceuticals ( CNSP ) +24% . Bullfrog AI ( BFRG ) +20% . SI-BONE ( SIBN ) +19% . Losers: ContraFect ( CFRX ) -24% . AdaptHealth ( AHCO ) ...

SI-BONE, Inc. (SIBN) Q4 2022 Earnings Conference Call February 27, 2023 4:30 PM ET Company Participants Saqib Iqbal - Director of Investor Relations Laura Francis - Chief Executive Officer Anshul Maheshwari - Chief Financial Officer Conference Call Participants ...

The following slide deck was published by SI-BONE, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: SI-BONE, Inc. 2022 Q4 - Results - Earnings Call Presentation

SI-BONE press release ( NASDAQ: SIBN ): Q4 GAAP EPS of -$0.32 beats by $0.07 . Revenue of $31.95M (+26.8% Y/Y) beats by $0.18M . Adjusted EBITDA loss improved in the fourth quarter 2022 by 54% to $4.2 million compared to $9.0 million in the prior year period. ...

SANTA CLARA, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the fourth quarter and full year ended December 31, 2022. Recent Fin...

SANTA CLARA, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter of 2022 after market close on Monday, Fe...